Anil Modak, the Associate Director of Medical Products R&D at Cambridge Isotope Laboratories, Andover, MA has been involved in the design, R&D of novel non invasive breath tests for personalized medicine using stable isotope substrates for the diagnosis of disease states and evaluation of enzyme activity. He is the author of several patents, publications and a book chapter. He serves on the Editorial board of the Journal of Breath Research and Journal of Pharmacogenomics & Pharmacoproteomics. His previous experience includes working for Ribozyme Pharmaceutical, Boulder, CO and Monsanto, St Louis, MO. His postdoctoral research was conducted at the University of Iowa and Kings College London. Anil Modak, the Associate Director of Medical Products R&D at Cambridge Isotope Laboratories, Andover, MA has been involved in the design, R&D of novel non invasive breath tests for personalized medicine using stable isotope substrates for the diagnosis of disease states and evaluation of enzyme activity. He is the author of several patents, publications and a book chapter. He serves on the Editorial board of the Journal of Breath Research and Journal of Pharmacogenomics & Pharmacoproteomics. His previous experience includes working for Ribozyme Pharmaceutical, Boulder, CO and Monsanto, St Louis, MO. His postdoctoral research was conducted at the University of Iowa and Kings College London.

Surgery and Medicine